ACM
ITCI

AlphaCrest Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

AlphaCrest Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$232K Sell
2022
Q2 		$584K Buy
2022
Q1 		– Sell
2021
Q4 		$241K Buy
2021
Q3 		– Sell
2021
Q2 		$212K Buy
2021
Q1 		– Sell
2020
Q4 		$264K Buy